Drug Shortage Report for APO-NAPROXEN EC

Last updated on 2018-08-09 History
Report ID 40354
Drug Identification Number 02246700
Brand name APO-NAPROXEN EC
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 375MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-19
Estimated end date 2018-08-31
Actual end date 2018-08-07
Shortage status Resolved
Updated date 2018-08-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-08-09 French Compare
v9 2018-08-09 English Compare
v8 2018-07-10 French Compare
v7 2018-07-10 English Compare
v6 2018-05-29 French Compare
v5 2018-05-29 English Compare
v4 2018-05-01 French Compare
v3 2018-05-01 English Compare
v2 2018-02-21 French Compare
v1 2018-02-21 English Compare

Showing 1 to 10 of 10